about
Antimalarial prophylaxis--efficacy or effectiveness?Characterization of drug resistance associated genetic polymorphisms among Plasmodium falciparum field isolates in Ujjain, Madhya Pradesh, IndiaChloroquine is grossly under dosed in young children with malaria: implications for drug resistanceTravel-associated infection presenting in Europe (2008-12): an analysis of EuroTravNet longitudinal, surveillance data, and evaluation of the effect of the pre-travel consultation.No seasonal accumulation of resistant P. falciparum when high-dose chloroquine is used.Genetic diversity among Plasmodium falciparum field isolates in Pakistan measured with PCR genotyping of the merozoite surface protein 1 and 2.High throughput resistance profiling of Plasmodium falciparum infections based on custom dual indexing and Illumina next generation sequencing-technology.Malaria transmission in Bissau, Guinea-Bissau between 1995 and 2012: malaria resurgence did not negatively affect mortalityPolymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine.Prevalence of resistance associated polymorphisms in Plasmodium falciparum field isolates from southern Pakistan.Similar efficacy and tolerability of double-dose chloroquine and artemether-lumefantrine for treatment of Plasmodium falciparum infection in Guinea-Bissau: a randomized trial.Paracetamol versus placebo in treatment of non-severe malaria in children in Guinea-Bissau: a randomized controlled trial.Temporal and seasonal changes of genetic polymorphisms associated with altered drug susceptibility to chloroquine, lumefantrine, and quinine in Guinea-Bissau between 2003 and 2012Drug resistance associated genetic polymorphisms in Plasmodium falciparum and Plasmodium vivax collected in Honduras, Central America.Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for Treatment of Uncomplicated Plasmodium falciparum Malaria in Children Aged Less than 15 Years in Guinea-Bissau - An Open-Label Non-Inferiority Randomised Clinical Trial.Plasmodium falciparum drug resistance phenotype as assessed by patient antimalarial drug levels and its association with pfmdr1 polymorphismsMicrobial hara-kiri: Exploiting lysosomal cell death in malaria parasites.Unexpected selections of Plasmodium falciparum polymorphisms in previously treatment-naïve areas after monthly presumptive administration of three different anti-malarial drugs in Liberia 1976-78.Single nucleotide polymorphisms in Plasmodium falciparum V type H(+) pyrophosphatase gene (pfvp2) and their associations with pfcrt and pfmdr1 polymorphisms.Patient med TBE förbättrades snabbt vid behandling med kortison - Evidens saknas dock för värdet av immunmodulerande terapi.Travel-related infection in European travelers, EuroTravNet 2011.High-Dose Chloroquine for Treatment of Chloroquine-Resistant Plasmodium falciparum Malaria.Multiplex PCR detection of Cryptosporidium sp, Giardia lamblia and Entamoeba histolytica directly from dried stool samples from Guinea-Bissauan children with diarrhoea.Different doses of amodiaquine and chloroquine for treatment of uncomplicated malaria in children in Guinea-Bissau: implications for future treatment recommendations.Carriers, channels and chloroquine efficacy in Guinea-Bissau.Chloroquine resistant P. falciparum prevalence is low and unchanged between 1990 and 2005 in Guinea-Bissau: an effect of high chloroquine dosage?Artemether-lumefantrine treatment failure despite adequate lumefantrine day 7 concentration in a traveller with Plasmodium falciparum malaria after returning from Tanzania.Influence of consecutive-day blood sampling on polymerase chain reaction-adjusted parasitological cure rates in an antimalarial-drug trial conducted in Tanzania.No pfmdr1 amplifications in samples from Guinea-Bissau and Liberia collected between 1981 and 2004.Chloroquine-resistant malaria in Malawi.Direct whole-genome sequencing of Plasmodium falciparum specimens from dried erythrocyte spots.Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: A pharmacokinetic-pharmacodynamic meta-analysis.High-Dose Chloroquine for Uncomplicated Plasmodium falciparum Malaria Is Well Tolerated and Causes Similar QT Interval Prolongation as Standard-Dose Chloroquine in Children
P50
Q26830480-2980B5EE-A01D-4AD0-85F8-93118370DBECQ28125942-1809BAE2-D477-49DC-BE64-E7D262C0B950Q28539103-C03E7F72-1C13-4746-AA0F-BBFD70FB88A2Q30369417-4D4F22F1-8EF4-4D27-9D03-1A30F5F7A8A8Q33498521-566CF0DC-DBBA-4CDB-A466-9385707DD2F6Q33590165-C85B9610-47F3-436E-8DBF-C196284773E0Q33729200-17D3A695-AAB9-4EC9-ABF7-3BABC69376A1Q33830762-38334EF3-571A-4EA1-8E22-E8C0C0F37628Q34281680-9650489D-4DAC-41F3-B5B1-211DEE3BA255Q34569732-C9822FBA-1A62-4ED2-B5A0-308A4905B5CEQ34910448-3BE3EAC9-F718-4B16-AC1D-F2A24D978F5EQ35069370-A78EEEFE-3E80-46FC-B39A-7F28AFBAC335Q35105975-1F42B307-B124-47D9-A541-1D9B301F6CF6Q35698213-71EB697C-B5E6-4412-A2D3-54E9AD35B67AQ36138583-7B5AB4F1-A8DC-4F2C-9C01-DC55273B98BBQ36584636-073A8AEF-008C-4ED4-A4B7-9AA4C29C6D66Q37705685-615737F1-5D4A-4D20-8DB1-5AECC9AC65C5Q39112462-B25D44DC-2DCC-4AAF-9D55-0D878DEF9AFCQ39112469-CD75E03B-7FAC-4479-8162-2A950301E09EQ40153049-50B450F7-C648-4478-85BC-594925EC14CEQ40209744-B32ED8EF-15D2-4D7B-B5F9-EE27D91C8DF9Q40223323-E6BD75BD-2717-4BDE-8AD5-5E48D3EABB75Q40236480-A6740671-4766-42C4-848F-83B922217AF1Q40298440-85493184-59A2-4265-92D6-A9959D360DF6Q41941738-1BF8E9A2-2B1C-4594-9344-2FDF7167A573Q41943112-CB8B5866-9B1C-4DAD-B895-DB87D967EF61Q42134574-33B1F4C1-EF5B-4727-AF8A-D3F7B0947AC2Q43946154-9AA07D16-05F5-4649-AB81-EAB62BB24573Q46512606-140219A7-8AFE-4E01-9EE9-C7C007519E50Q46878814-4388BDDA-A864-4F28-9F2A-ACB107E6C898Q50104729-52E5AAEF-8272-48A5-B35F-18B4A352530EQ55449589-DDE2B891-9FF2-4E4D-B07F-CD1F2EDA3318Q92452211-3FD8C2B6-66D3-4FC7-B43C-372A67BEA002
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Johan Ursing
@ast
Johan Ursing
@en
Johan Ursing
@es
Johan Ursing
@nl
Johan Ursing
@sl
type
label
Johan Ursing
@ast
Johan Ursing
@en
Johan Ursing
@es
Johan Ursing
@nl
Johan Ursing
@sl
prefLabel
Johan Ursing
@ast
Johan Ursing
@en
Johan Ursing
@es
Johan Ursing
@nl
Johan Ursing
@sl
P106
P21
P31
P496
0000-0002-5508-9327